Roche Backs Full-Year View as First-Half Sales Rise
Roche Holding ROP 0.00%increase; up pointing triangle backed its full-year guidance as its pharmaceuticals division helped drive a…
UH Geneva receives award for patient service | News
GENEVA — The cafeteria at UH Geneva Medical Center became the center of a celebration center Wednesday morning,…
More men in Switzerland are turning to testosterone replacement therapy
Testosterone is increasingly being prescribed to older men looking to counter symptoms commonly linked to ageing, such as…
More men in Switzerland are turning to testosterone replacement therapy
Testosterone is increasingly being prescribed to older men looking to counter symptoms commonly linked to ageing, such as…
More men in Switzerland are turning to testosterone replacement therapy
Testosterone is increasingly being prescribed to older men looking to counter symptoms commonly linked to ageing, such as…
How Novartis R&D is advancing the next breakthrough innovations
Novartis is moving earlier, thinking differently, and making deliberate scientific choices to tackle some of medicine’s most complex…
Finger Lakes Health expands pediatric care in Geneva | Health
GENEVA — University of Rochester Medicine Finger Lakes Health is expanding its pediatric services into Geneva under the…
Keck School of Medicine of USC and Novartis collaborate to eliminate breast cancer screening barriers
Compelled by disparities in breast cancer outcomes, the Keck School of Medicine of USC’s Department of Population and…
Light switch makes cancer vulnerable to attack
Tumour cells can lapse into a sleep-like state and thereby evade the destructive effect of cancer drugs. In…
New drug could slow the development of Alzheimer’s
“Compound 10” is how Ursula Quitterer refers to the chemical compound that her team has developed and which…
Novartis Acquires Pikavation for Up to $3B, Expanding Cancer Pipeline
Novartis has committed up to $3 billion—two-thirds of that upfront—toward acquiring Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics…
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
Clinically meaningful, statistically significant efficacy achieved in primary and all secondary endpoints, including reduced steroid use; safety consistent…